ES2068151A1 - Microespuma inyectable para esclerosis. - Google Patents

Microespuma inyectable para esclerosis.

Info

Publication number
ES2068151A1
ES2068151A1 ES09301413A ES9301413A ES2068151A1 ES 2068151 A1 ES2068151 A1 ES 2068151A1 ES 09301413 A ES09301413 A ES 09301413A ES 9301413 A ES9301413 A ES 9301413A ES 2068151 A1 ES2068151 A1 ES 2068151A1
Authority
ES
Spain
Prior art keywords
microfoam
sclerosing
sclerosing agent
injectable
sclerotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301413A
Other languages
English (en)
Other versions
ES2068151B1 (es
Inventor
Garrido Juan Ramon Cabrera
Garcia-Olmedo Juan Cabrera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8282315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2068151(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to ES09301413A priority Critical patent/ES2068151B1/es
Priority to AT94918886T priority patent/ATE179598T1/de
Priority to PCT/ES1994/000064 priority patent/WO1995000120A1/es
Priority to DE69418286T priority patent/DE69418286T2/de
Priority to EP94918886A priority patent/EP0656203B3/en
Priority to AU70012/94A priority patent/AU7001294A/en
Priority to DK94918886T priority patent/DK0656203T3/da
Priority to ES94918886T priority patent/ES2131689T7/es
Priority to US08/407,595 priority patent/US5676962A/en
Publication of ES2068151A1 publication Critical patent/ES2068151A1/es
Publication of ES2068151B1 publication Critical patent/ES2068151B1/es
Application granted granted Critical
Priority to GR990401341T priority patent/GR3030248T3/el
Priority to US10/458,806 priority patent/USRE38919E1/en
Priority to US10/941,013 priority patent/USRE40640E1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/07—Microporous membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

MICROESPUMA INYECTABLE PARA ESCLEROSIS. PROCEDIMIENTO PARA LA ELABORACION DE MICROESPUMA INYECTABLE PARA USOS TERAPEUTICOS. LA ESCLEROSIS DE VARICES SE BASA EN LA INYECCION DE SUSTANCIAS LIQUIDAS DE CONOCIDA CAPACIDAD PARA SUPRIMIRLAS. LA PRESENTE INVENCION SE REFIERE A LA PREPARACION DE SUSTANCIAS ESCLEROSANTES EN FORMA DE MICROESPUMA. AL ELABORAR LA MICROESPUMA CON ESCLEROSANTES, Y SU POSTERIOR INYECCION EN LA VENA A TRATAR, ESTA MICROESPUMA DESPLAZA LA SANGRE QUE CONTIENE LA VENA Y GARANTIZA EL CONTACTO DEL ESCLEROSANTE CON EL ENDOTELIO DEL VASO, A CONCENTRACION CONOCIDA Y DURANTE UN TIEMPO CONTROLABLE.
ES09301413A 1993-06-23 1993-06-23 Microespuma inyectable para esclerosis. Expired - Lifetime ES2068151B1 (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ES09301413A ES2068151B1 (es) 1993-06-23 1993-06-23 Microespuma inyectable para esclerosis.
DK94918886T DK0656203T3 (da) 1993-06-23 1994-06-21 Injicerbart mikroskum indeholdende et scleroserende middel
PCT/ES1994/000064 WO1995000120A1 (es) 1993-06-23 1994-06-21 Microespuma inyectable conteniendo un agente esclerosante
DE69418286T DE69418286T2 (de) 1993-06-23 1994-06-21 Injizierbarer Mikroschaum, der ein Verödungsmittel enthält
EP94918886A EP0656203B3 (en) 1993-06-23 1994-06-21 Injectable microfoam containing a sclerosing agent
AU70012/94A AU7001294A (en) 1993-06-23 1994-06-21 Injectable microfoam containing a sclerosing agent
AT94918886T ATE179598T1 (de) 1993-06-23 1994-06-21 Injizierbarer mikroschaum, der ein verödungsmittel enthält
ES94918886T ES2131689T7 (es) 1993-06-23 1994-06-21 Microespuma inyectable que contiene un agente esclerosante.
US08/407,595 US5676962A (en) 1993-06-23 1995-02-23 Injectable microfoam containing a sclerosing agent
GR990401341T GR3030248T3 (en) 1993-06-23 1999-05-19 Injectable microfoam containing a sclerosing agent.
US10/458,806 USRE38919E1 (en) 1993-06-23 2003-06-11 Injectable microfoam containing a sclerosing agent
US10/941,013 USRE40640E1 (en) 1993-06-23 2004-09-15 Injectable microfoam containing a sclerosing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09301413A ES2068151B1 (es) 1993-06-23 1993-06-23 Microespuma inyectable para esclerosis.

Publications (2)

Publication Number Publication Date
ES2068151A1 true ES2068151A1 (es) 1995-04-01
ES2068151B1 ES2068151B1 (es) 1995-11-16

Family

ID=8282315

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09301413A Expired - Lifetime ES2068151B1 (es) 1993-06-23 1993-06-23 Microespuma inyectable para esclerosis.
ES94918886T Active ES2131689T7 (es) 1993-06-23 1994-06-21 Microespuma inyectable que contiene un agente esclerosante.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES94918886T Active ES2131689T7 (es) 1993-06-23 1994-06-21 Microespuma inyectable que contiene un agente esclerosante.

Country Status (9)

Country Link
US (3) US5676962A (es)
EP (1) EP0656203B3 (es)
AT (1) ATE179598T1 (es)
AU (1) AU7001294A (es)
DE (1) DE69418286T2 (es)
DK (1) DK0656203T3 (es)
ES (2) ES2068151B1 (es)
GR (1) GR3030248T3 (es)
WO (1) WO1995000120A1 (es)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2216708A1 (es) * 2003-04-08 2004-10-16 Antonio Luis Cabrera Garrido "solucion esclerosante".
USRE38919E1 (en) 1993-06-23 2005-12-13 Btg International Limited Injectable microfoam containing a sclerosing agent
US7025290B2 (en) 1999-05-26 2006-04-11 Btg International Limited Generation of therapeutic microfoam
US7731986B2 (en) 2003-11-17 2010-06-08 Btg International Ltd. Therapeutic foam
US8048439B2 (en) 2003-11-17 2011-11-01 Btg International Ltd. Therapeutic foam
US8512680B2 (en) 2001-08-08 2013-08-20 Btg International Ltd. Injectables in foam, new pharmaceutical applications
US8703827B2 (en) 2005-05-13 2014-04-22 Btg International Ltd. Therapeutic foam

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
AU2005205772B2 (en) * 1999-05-26 2009-04-30 Btg International Limited Generation of Therapeutic Microfoam
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US20030120256A1 (en) * 2001-07-03 2003-06-26 Syntheon, Llc Methods and apparatus for sclerosing the wall of a varicose vein
US7077836B2 (en) * 2000-07-21 2006-07-18 Vein Rx, Inc. Methods and apparatus for sclerosing the wall of a varicose vein
GB0028692D0 (en) * 2000-11-24 2001-01-10 Btg Int Ltd Generation of therapeutic microform
GB2369996B (en) * 2000-12-18 2004-06-23 S T D Pharmaceutical Products Method and apparatus for producing an injectable foam
ES2346955T3 (es) * 2001-08-08 2010-10-22 Btg International Limited Espuma inyectable y aplicaciones farmaceuticas novedosas de la misma.
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
EP1488601A1 (en) * 2002-03-28 2004-12-22 British Telecommunications Public Limited Company Synchronisation in multi-modal interfaces
GB0212047D0 (en) 2002-05-24 2002-07-03 Btg Int Ltd Generation of therapeutic microfoam
GB0300586D0 (en) * 2003-01-10 2003-02-12 Btg Int Ltd Therapeutic microfoam
US7314466B2 (en) * 2003-10-02 2008-01-01 Lary G Banning Minimally invasive vascular surgery
ES2247898B1 (es) * 2003-12-18 2006-12-01 Universidad Complutense De Madrid Utilizacion de una inyeccion previa de polidocamol en forma de microespuma para la extirpacion indolora de varices mediante laser.
ITMI20041056A1 (it) * 2004-05-26 2004-08-26 Garrido Antonio Luis Cabrera Uso in campo medico diagnostico e flebo logico di una kiscela di gas sterili e fisiologicamente accettabili
WO2006076699A1 (en) * 2005-01-14 2006-07-20 Vein Rx, Inc. Valve system for a medical device having an inflatable member
US8469924B2 (en) 2006-04-04 2013-06-25 Covidien Lp Method and apparatus for generating vascular treatment foam
US9307995B2 (en) * 2006-06-15 2016-04-12 Cook Medical Technologies Llc Methods, systems and devices for the delivery of endoluminal prostheses
US20080050436A1 (en) * 2006-08-25 2008-02-28 Chu Jack F Methods and compounds for obliteration of vessels
US20190070397A1 (en) * 2006-11-27 2019-03-07 Frank Levy Apparatus and method for producing co2 enriched medical foam
SI2125322T1 (sl) 2006-12-21 2013-07-31 Btg International Limited Naprava in postopek za izdelavo terapevtske pene
EP2187983B1 (en) * 2007-09-12 2014-04-16 Cook Incorporated Enhanced remodelable materials for occluding bodily vessels
US8157747B2 (en) 2008-02-15 2012-04-17 Lary Research & Development, Llc Single-use indicator for a surgical instrument and a surgical instrument incorporating same
BRPI1008909B8 (pt) * 2009-02-20 2021-06-22 Covidien Lp sistema para tratar uma veia
US9427233B2 (en) 2011-06-06 2016-08-30 Cook Medical Technologies, LLC Vascular occlusion devices and methods
WO2013013080A1 (en) 2011-07-20 2013-01-24 Sapheon, Inc. Enhanced ultrasound visualization of intravascular devices
US8808620B1 (en) 2012-02-22 2014-08-19 Sapheon, Inc. Sterilization process design for a medical adhesive
JP2012246306A (ja) * 2012-08-22 2012-12-13 Btg Internatl Ltd 注射可能な泡製剤および新規な医薬的適用
US20160346423A1 (en) 2014-01-07 2016-12-01 Covidien Lp Cyanoacrylate compositions including non-agglomerating radiopaque nanoparticles
EP3151951B8 (en) 2014-06-03 2020-08-05 Vascular Barcelona Devices, S.L. Methods, devices, systems and kits for preparing compositions for care and repair of varicose veins
EP2962681A1 (en) 2014-07-03 2016-01-06 Swiss VX Venentherapie und Forschung GmbH Devices and methods for injectable vascular sclerofoams using a carrier made of human blood and uses thereof
US20160045416A1 (en) * 2014-08-14 2016-02-18 John Daniel Dobak Ethanolamine oleate formulations for treatment of adipose tissue
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
GB201611778D0 (en) 2016-07-06 2016-08-17 Provensis Ltd Method and device for producing foam
GB201612925D0 (en) * 2016-07-26 2016-09-07 Provensis Ltd Method and device for generating injectable foam
WO2019178579A1 (en) 2018-03-16 2019-09-19 Boston Scientific Scimed, Inc. Devices for vein closure
IT201800006109A1 (it) 2018-06-07 2019-12-07 Polidocanolo per uso come immunomodulatore
AU2023371657A1 (en) 2022-11-04 2025-05-15 Solvein Inc. Catheters and related methods for aspiration and controlled delivery of closure agents
US11911581B1 (en) 2022-11-04 2024-02-27 Controlled Delivery Systems, Inc. Catheters and related methods for the aspiration controlled delivery of closure agents
WO2026039577A1 (en) 2024-08-13 2026-02-19 Solvein, Inc. Device of vein treatment using coiled abrasion elements

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466442A (en) * 1981-10-16 1984-08-21 Schering Aktiengesellschaft Carrier liquid solutions for the production of gas microbubbles, preparation thereof, and use thereof as contrast medium for ultrasonic diagnostics
EP0324938A1 (en) * 1987-12-29 1989-07-26 Molecular Biosystems, Inc. Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production
WO1992005806A1 (en) * 1990-10-05 1992-04-16 Sintetica S.A. Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1547768A (fr) 1967-10-09 1968-11-29 Récipient remplissable à dispositif décompresseur
FR2105332A5 (es) 1970-09-01 1972-04-28 Oreal
US3955720A (en) 1972-11-15 1976-05-11 Malone David C Low pressure dispensing apparatus with air pump
US3970219A (en) 1975-03-03 1976-07-20 Spitzer Joseph G Aerosol containers for foaming and delivering aerosols and process
US4019657A (en) 1975-03-03 1977-04-26 Spitzer Joseph G Aerosol containers for foaming and delivering aerosols
US4040420A (en) 1976-04-22 1977-08-09 General Dynamics Packaging and dispensing kit
US4127131A (en) 1977-06-20 1978-11-28 Johnson & Johnson Hub assembly for use in the filtration of fluids and method of making the same
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4292972A (en) 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam
DE3048774C2 (de) 1980-12-23 1984-03-08 B. Braun Melsungen Ag, 3508 Melsungen Katheterisierungsvorrichtung
DE3050812C2 (de) 1980-12-23 1985-03-21 B. Braun Melsungen Ag, 3508 Melsungen Katheterisierungsvorrichtung
DE3048744A1 (de) 1980-12-23 1982-07-22 Metzeler Kautschuk GmbH, 8000 München Anordnung zum abdichten einer mehrscheibenverglasung
US4718433A (en) 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
US5141738A (en) 1983-04-15 1992-08-25 Schering Aktiengesellschaft Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof
DE3313947A1 (de) 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
DE3324754A1 (de) 1983-07-06 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen Ultraschallkontrastmittel sowie dessen herstellung
DE3417182A1 (de) 1984-05-09 1985-11-14 Gerald Dr. 8000 München Hauer Spritzen-set
GB8522813D0 (en) 1985-09-16 1985-10-23 Unilever Plc Package
DE8704600U1 (de) 1987-03-27 1987-10-15 Cocon Kunststoffen B.V., Arkel Vorrichtung zur gebrauchsfertigen Zubereitung der beiden Komponenten eines zweikomponentigen Montageschaums, insbesondere Polyurethanschaums
CH676456A5 (es) 1988-04-05 1991-01-31 Supermatic Kunststoff Ag
US4957656A (en) 1988-09-14 1990-09-18 Molecular Biosystems, Inc. Continuous sonication method for preparing protein encapsulated microbubbles
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5084011A (en) 1990-01-25 1992-01-28 Grady Daniel J Method for oxygen therapy using hyperbarically oxygenated liquid
US5064103A (en) 1990-05-23 1991-11-12 Rjs Industries, Inc. Foam dispenser having a plurality of sieves
FR2672038B1 (fr) 1991-01-25 1993-05-14 Oreal Dispositif distributeur de mousse a partir d'un recipient pressurise.
DE4301820C2 (de) 1993-01-23 1996-04-25 Henkel Kgaa Schäumende Emulsionen, Verfahren zu ihrer Herstellung und ihre Verwendung
NL9300517A (nl) 1993-03-23 1994-10-17 Airspray Int Bv Schuimvormingssamenstel, een daarvoor geschikte spuitkop en een spuitbus die een dergelijk samenstel omvat.
ES2068151B1 (es) 1993-06-23 1995-11-16 Cabrera Garrido Juan Microespuma inyectable para esclerosis.
US5623085A (en) 1994-09-23 1997-04-22 Rohm And Haas Company Method for reducing microfoam in a spray-applied waterborne composition
AU3896395A (en) 1994-10-11 1996-05-02 James A. Monson Dispensing apparatus for foaming compositions and method
GB9503119D0 (en) 1995-02-17 1995-04-05 Durand Ltd Medication and apparatus and method of applying medication
GB9823029D0 (en) 1998-10-22 1998-12-16 Giltech Ltd Packaging system
FR2775433A1 (fr) 1998-02-27 1999-09-03 Alain Monfreux Dispositif pour la production de mousse dans un corps de seringue
FR2775436A1 (fr) 1998-02-27 1999-09-03 Alain Monfreux Dispositif pour l'administration parenterale d'une composition sous forme d'une mousse
DE29819174U1 (de) 1998-10-28 1999-01-28 Kurt Vogelsang GmbH, 74855 Haßmersheim Schutzkappe für eine Zweikomponenten-Lack-Sprühdose
ES1043183Y (es) 1999-05-03 2000-04-01 Mingo Fco Javier Garcia Dispositivo para producir esclerosante espumado.
GB9912356D0 (en) 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
US6561237B1 (en) 2000-11-28 2003-05-13 Brasscorp Ltd. Apparatus and method for urging fluid into a pressurized system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466442A (en) * 1981-10-16 1984-08-21 Schering Aktiengesellschaft Carrier liquid solutions for the production of gas microbubbles, preparation thereof, and use thereof as contrast medium for ultrasonic diagnostics
EP0324938A1 (en) * 1987-12-29 1989-07-26 Molecular Biosystems, Inc. Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production
WO1992005806A1 (en) * 1990-10-05 1992-04-16 Sintetica S.A. Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38919E1 (en) 1993-06-23 2005-12-13 Btg International Limited Injectable microfoam containing a sclerosing agent
US7025290B2 (en) 1999-05-26 2006-04-11 Btg International Limited Generation of therapeutic microfoam
US7357336B2 (en) 1999-05-26 2008-04-15 Btg International Limited Generation of therapeutic microfoam
US7604185B2 (en) 1999-05-26 2009-10-20 Btg International Ltd. Generation of therapeutic microfoam
US8512680B2 (en) 2001-08-08 2013-08-20 Btg International Ltd. Injectables in foam, new pharmaceutical applications
ES2216708A1 (es) * 2003-04-08 2004-10-16 Antonio Luis Cabrera Garrido "solucion esclerosante".
WO2004089358A1 (es) * 2003-04-08 2004-10-21 Antonio Luis Cabrera Garrido Solución esclerosante
US7731986B2 (en) 2003-11-17 2010-06-08 Btg International Ltd. Therapeutic foam
US7763269B2 (en) 2003-11-17 2010-07-27 Btg International Ltd. Therapeutic foam
US8048439B2 (en) 2003-11-17 2011-11-01 Btg International Ltd. Therapeutic foam
US8323677B2 (en) 2003-11-17 2012-12-04 Btg International Ltd. Therapeutic foam
US8703827B2 (en) 2005-05-13 2014-04-22 Btg International Ltd. Therapeutic foam

Also Published As

Publication number Publication date
USRE40640E1 (en) 2009-02-17
EP0656203B3 (en) 2011-01-26
WO1995000120A1 (es) 1995-01-05
US5676962A (en) 1997-10-14
AU7001294A (en) 1995-01-17
ES2131689T3 (es) 1999-08-01
ES2131689T7 (es) 2012-03-16
DK0656203T3 (da) 1999-11-01
ES2068151B1 (es) 1995-11-16
GR3030248T3 (en) 1999-08-31
EP0656203A1 (en) 1995-06-07
EP0656203B1 (en) 1999-05-06
DE69418286T2 (de) 1999-10-14
DE69418286D1 (de) 1999-06-10
ATE179598T1 (de) 1999-05-15
USRE38919E1 (en) 2005-12-13

Similar Documents

Publication Publication Date Title
ES2068151A1 (es) Microespuma inyectable para esclerosis.
Sicuteri et al. Serotonin—bradykinin potentiation on the pain receptors in man
EP0289342A3 (en) Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
GR3026707T3 (en) Facilitated oxygen delivery in conjunction with hemodilution.
ATE219683T1 (de) Verfahren und zubereitungen zur verzoegerung oder vorbeugung von autoimmun krankheiten
ATE311192T1 (de) Verfahren zur behandlung von chronischen geschwüren
ATE163654T1 (de) Überkritische flüssigkeitsextraktion mit hydrofluoralkanen
IL103383A0 (en) Pharmaceutical compositions containing glutamine and methods for the use thereof
Wolfson Jr et al. Effects of glucagon on plasma potassium.
ES2147962T3 (es) Dispositivo para inyectar un liquido en alimentos.
KR900702018A (ko) 단백질과 핵산
NO941546L (no) Transdermale butyrofenonblandinger
GB8629639D0 (en) Composition & method
Obermaier et al. Exogenous and endogenous nitric oxide donors improve post-ischemic tissue oxygenation in early pancreatic ischemia/reperfusion injury in the rat
RU95113856A (ru) Способ лечения окклюзирующих поражений сосудов сетчатки и зрительного нерва
KR890014099A (ko) 펜에탄올아민 및 성장 호르몬 혼합물
RU93052523A (ru) Способ лечения орхоэпидидимита
GERSHUNI et al. Decompression of an experimental compartment syndrome in dogs with hyaluronidase
Ayyappan et al. Origin and Evolution of Sclerotherapy for Varicose Veins
JPS5779847A (en) Penetration of effective food into food
SU1666118A1 (ru) Способ лечени невралгии тройничного нерва
Diffang et al. The effect of alpha-blocking agents on the amount of intravascular fibrin in the lungs during induced intravascular coagulation in rats
JPS6466130A (en) High polymer carcinostatic enhancer
Krüger New aspects of haemangioma treatment
RU93032564A (ru) Способ остановки кровоточения при аденомэктомии простаты